Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · View financials
Decision snapshot: GDRX stock price vs MLKN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MLKN's multiple
Needs MLKN P/E.
Implied fair value · at GDRX's multiple
Needs GDRX P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: GDRX FY 2025 (ended Dec 31, 2025) · MLKN FY 2026 (ended May 30, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
GoodRx Holdings, Inc. · implied price per share
Bear
$2.87
Base
$3.38
Bull
$3.88
MillerKnoll, Inc. · implied price per share
Bear
$11.93
Base
$14.03
Bull
$16.14
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.81x
0.96x
Net debt / EBITDA
Leverage against operating earnings
1.26x
2.74x
Cash and equivalents
Liquid reserves on the balance sheet
$261.82M
$174.70M
Total debt
Interest-bearing obligations outstanding
$500.00M
$1.29B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe GDRX can sustain its current profitability and avoid deterioration in distress metrics, then holding or selectively accumulating makes sense because it trades below the DCF range and far above MLKN-implied downside despite better margins and lower leverage than MLKN.
GDRX is trading at $3.05, which is below the DCF range of $3.44-$4.65 and slightly above the historical band low of $2.75, but far above MLKN-implied price of $0.89. The valuation gap is driven by the fact that GDRX carries a higher P/S multiple than MLKN, while also showing meaningfully better margins and lower leverage.
Supporting Metrics
Live quote
